Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2022

Revenue From Contract With Customer [Abstract]

Schedule of Timing of Revenue Recognition

The following table illustrates the timing of the Company’s revenue recognition:

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Software products and services – point in time		45.8	%		51.9	%		45.2	%		53.0	%
Software products and services – over time		32.2			28.8			27.2			28.4
Drug Discovery – point in time		3.5			4.3			12.2			2.1
Drug Discovery – over time		18.5			15.0			15.4			16.5

Schedule of Revenue Recognized from the Sources of Software Products and Services Revenue

The following table presents the revenue recognized from the sources of software products and services revenue:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
On-premise software	$	16,595	$	14,452	$	38,281	$	31,807
Hosted software		3,596		2,704		6,851		5,304
Software maintenance		4,952		4,176		9,678		8,281
Professional services		3,868		1,720		7,282		4,000
Revenue from contracts with customers		29,011		23,052		62,092		49,392
Software contribution		1,000		1,000		1,000		1,000
Total software revenue	$	30,011	$	24,052	$	63,092	$	50,392

Drug Discovery Revenue

The following table presents the revenue recognized from the sources of drug discovery revenue:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Drug discovery services revenue from contracts with customers	$	8,019	$	5,732	$	23,259	$	11,519
Drug discovery contribution		439		—		781		—
Total drug discovery revenue	$	8,458	$	5,732	$	24,040	$	11,519

Schedule of Contract Balances

Contract balances were as follows:

	As of June 30,		As of December 31,
	2022		2021
Contract assets	$	12,015	$	8,271
Deferred revenue, short-term:
Software products and services		24,815		32,945
Drug discovery		22,625		22,423
Deferred revenue, long-term:
Software products and services		3,641		3,938
Drug discovery		16,464		26,126